Using comprehensive pan-cancer analysis, activated epithelial-mesenchymal transition (EMT) is identified as a highly conserved biological process across multiple cancer types, and further investigation on CRC revealed that high-risk patients were associated with the mesenchymal subtype, activated stromal infiltration and poor anti-EGFR therapeutic response 97. Here, EGFR is linked to cancer.